Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 180-184, November 2009

Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose

Department of Radiation-Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Received 10 October 2008; received in revised form 19 April 2009; accepted 28 June 2009. published online 25 August 2009.

Abstract 

In the previous decades the distinction between a local relapse and distant metastases was difficult to accomplish in an early stage. As a consequence, a failure could only be coarsely related to the original radiotherapy treatment. Currently, due to better imaging and position verification techniques, the actual dose within the prostate can be estimated, taking position uncertainties into account. Furthermore, advanced functional MRI techniques, such as MR spectroscopy (MRS) and dynamic contrast-enhanced MRI (DCE-MRI), increase the chance of localizing a local recurrence within the prostate. With this information the correlation between the actual previously delivered dose and a local relapse can be established, using non-rigid registration of the planning CT and the post-recurrence MRI. The current study describes the possibilities and problems in obtaining this correlation. This serves as a framework for investigating a reliable dose effect relationship in the future.

Keywords: Dose–response relationship, Prostate, Local recurrence, Tumor control probability, Radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00429-0

doi:10.1016/j.radonc.2009.06.033

Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 180-184, November 2009